Table 1 Summary of histology, VH gene usage and frequency of somatic and ongoing mutations in eight patients with B-NHLs
Patient no. | Histology | VH usage | Somatic mutation (%) | Ongoing mutation |
---|---|---|---|---|
52 | DLBCL | VH3-23 | 12.77 | 0.113 |
53 | MCL | VH3-23 | 0 | 0 |
54 | DLBCL | VH3-11 | 6.84 | 0.148 |
55 | MALT-L | VH3-21 | 5.42 | 0.113 |
56 | DLBCL | VH3-30 | 3.55 | 0.090 |
57 | DLBCL | VH3-33 | 16.31 | 0.254 |
58 | DLBCL | VH3-43 | 9.28 | 0.157 |